Delivery Order SPE2DB20D7059-SPE2DB25FPYW5

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of NITROFURANTOIN MONO-MCR 100 MG 1000S. The contract has a ceiling value of $14,522.98 and is a Firm Fixed Price Delivery Order contract that runs through November 24, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,962.11 firm fixed-price delivery order is for the supply of 4,566,995,841 units of NITROFURANTOIN MONO-MCR 100 MG 1000S, a generic pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,697.66 firm-fixed-price delivery order is for the supply of 4,564,937,473 units of the drug Nitrofurantoin Mono-MCR 100 mg, with a completion date of June 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award, valued at $2,964.53, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corporation. The contract provides for the delivery of 4564000805 - NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, with a completion date of March 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, to provide a...
This federal contract award, valued at $14,671.65, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,232.23 firm fixed-price delivery order (SPE2DB22D1202|SPE2DB24FVGD0) is for the supply of 100 capsules of the drug Nitrofurantoin MCR 25 mg. The contract has an ultimate completion date of July 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, ID SPE2DX15D1053|SPE2DX25F6EYG, is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,341.73 Firm Fixed Price contract is for the supply of 240 ml bottles of the generic medication Nitrofurantoin 25 mg/5 ml suspension. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $21,729.04, was issued by the Medical Supply Chain division of the U.S. Department of Defense to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,287,193 units of the pharmaceutical product Nitrofurantoin Mono-MCR 100 mg. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $1,224.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4566340880 - NITROFURANTOIN 25 MG/5 ML SUSP 230ML, with an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $3,071.57 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4562259384 Nitrofurantoin Mono-MCR 100 mg tablets, 100 per bottle. The contract has a completion date of September 11, 2023 and was awarded on September 8, 2023. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business type. Amerisourcebergen Drug Corp...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FPYW5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,301.85 firm fixed-price delivery order is for NITROFURANTOIN MONO-MCR 100 MG 100S, a generic medication. The award is not associated with a set-aside program.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through streamlined contracting mechanisms.

Generated 4/29/25, 9:50 AM